Biovie (BIVI) Intangibles (2016 - 2026)
Biovie (BIVI) posted Intangibles of $6308.0 for Q1 2026, down 90.09% sequentially from $63653.0 in Q4 2025, and down 97.32% YoY from $235685.0 in Q1 2025.
Biovie (BIVI) Intangibles (2016 - 2026) Analysis & Trends
Biovie has reported Intangibles for 11 years, with the latest figure at $6308.0 in Q1 2026.
- Quarterly Intangibles fell 97.32% year-over-year to $6308.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6308.0 (down 97.32% YoY) and the FY2025 annual result came in at $178341.0, down 56.26% from the prior year.
- Intangibles slipped to $6308.0 in Q1 2026 per BIVI's latest filing, from $63653.0 in the prior quarter.
- Over five years, Intangibles peaked at $923817.0 in Q1 2022 and troughed at $6308.0 in Q1 2026.
- A 5-year average of $465062.4 and a median of $465062.0 in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2022 and 2026: Intangibles retreated 19.89% in 2022, then plunged 97.32% in 2026.
- Over 5 years, Intangibles stood at $751784.0 in 2022, then sank by 30.51% to $522407.0 in 2023, then tumbled by 43.91% to $293030.0 in 2024, then plunged by 78.28% to $63653.0 in 2025, then slumped by 90.09% to $6308.0 in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $6308.0, $63653.0, and $120997.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Biovie | 14.17 Mn | 14.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,308.00 |
| Dec 31, 2025 | 63,653.00 |
| Sep 30, 2025 | 120,997.00 |
| Jun 30, 2025 | 178,341.00 |
| Mar 31, 2025 | 235,685.00 |
| Dec 31, 2024 | 293,030.00 |
| Sep 30, 2024 | 350,374.00 |
| Jun 30, 2024 | 407,718.00 |
| Mar 31, 2024 | 465,062.00 |
| Dec 31, 2023 | 522,407.00 |
| Sep 30, 2023 | 579,751.00 |
| Jun 30, 2023 | 637,095.00 |
| Mar 31, 2023 | 694,439.00 |
| Dec 31, 2022 | 751,784.00 |
| Sep 30, 2022 | 809,128.00 |
| Jun 30, 2022 | 866,472.00 |
| Mar 31, 2022 | 923,817.00 |
| Dec 31, 2021 | 981,161.00 |
| Sep 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | 1.10 Mn |